Drug shortages homepage
Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.
A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.
Below are the newest and most recently updated Shortage and Discontinuation reports.
Shortage Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| VASERETIC | MERCK CANADA INC | Resolved | 8MG 25MG | Updated Report | 2020-05-26 | 113158 |
| DEFEROXAMINE MESYLATE FOR INJECTION | PFIZER CANADA ULC | Resolved | 2G | Updated Report | 2020-05-26 | 110345 |
| FOSRENOL | SHIRE PHARMA CANADA ULC | Actual shortage | 250MG | Updated Report | 2020-05-26 | 115725 |
| BRIVLERA | UCB CANADA INC | Actual shortage | 10MG | Updated Report | 2020-05-26 | 115679 |
| PRIVA-PRAVASTATIN | PHARMAPAR INC | Actual shortage | 10MG | Updated Report | 2020-05-25 | 98597 |
| PRIVA-PRAVASTATIN | PHARMAPAR INC | Actual shortage | 20MG | Updated Report | 2020-05-25 | 98600 |
| PRIVA-PRAVASTATIN | PHARMAPAR INC | Actual shortage | 40MG | Updated Report | 2020-05-25 | 98604 |
| PROTOPIC | LEO PHARMA INC | Anticipated shortage | 0.1% | Updated Report | 2020-05-25 | 115732 |
| PROTOPIC | LEO PHARMA INC | Anticipated shortage | 0.03% | Updated Report | 2020-05-25 | 115716 |
| REVATIO | PFIZER CANADA ULC | Actual shortage | 0.8MG | Updated Report | 2020-05-25 | 110817 |
Discontinuation Reports
| Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
|---|---|---|---|---|---|---|
| BELSOMRA | MERCK CANADA INC | Discontinued | 20MG | New Report | 2020-05-15 | 115276 |
| BELSOMRA | MERCK CANADA INC | Discontinued | 15MG | New Report | 2020-05-15 | 115273 |
| BELSOMRA | MERCK CANADA INC | Discontinued | 10MG | Updated Report | 2020-05-15 | 115269 |
| ACT DILTIAZEM T | ACTAVIS PHARMA COMPANY | Discontinued | 300MG | New Report | 2020-05-14 | 115126 |
| ACT DILTIAZEM T | ACTAVIS PHARMA COMPANY | Discontinued | 240MG | New Report | 2020-05-14 | 115123 |
| ACT DILTIAZEM T | ACTAVIS PHARMA COMPANY | Discontinued | 180MG | New Report | 2020-05-14 | 115120 |
| ACT DILTIAZEM T | ACTAVIS PHARMA COMPANY | Discontinued | 120MG | New Report | 2020-05-14 | 115117 |
| ACT DILTIAZEM T | ACTAVIS PHARMA COMPANY | Discontinued | 360MG | New Report | 2020-05-14 | 115114 |
| TEVA-TRIAMTERENE/HCTZ | TEVA CANADA LIMITED | Discontinued | 50MG 25MG | New Report | 2020-05-14 | 115091 |
| CEFOXITIN FOR INJECTION | TEVA CANADA LIMITED | Discontinued | 10G | New Report | 2020-05-14 | 115088 |
| TEVA-ARIPIPRAZOLE | TEVA CANADA LIMITED | Discontinued | 2MG | New Report | 2020-05-14 | 115085 |
| ACT RANITIDINE | TEVA CANADA LIMITED | Discontinued | 300MG | New Report | 2020-05-14 | 115082 |
| ACT RANITIDINE | TEVA CANADA LIMITED | Discontinued | 150MG | New Report | 2020-05-14 | 115079 |
| RAN-CLARITHROMYCIN | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 250MG | New Report | 2020-05-14 | 115059 |
| RAN-AMLODIPINE | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 10MG | New Report | 2020-05-14 | 115052 |
| RAN-AMLODIPINE | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 10MG | New Report | 2020-05-14 | 115049 |
| RAN-AMLODIPINE | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 5MG | New Report | 2020-05-14 | 115046 |
| RAN-AMLODIPINE | RANBAXY PHARMACEUTICALS CANADA INC. | Discontinued | 5MG | New Report | 2020-05-14 | 115038 |
| TARO-AMCINONIDE | TARO PHARMACEUTICALS INC | Discontinued | 0.1% | New Report | 2020-05-14 | 115031 |
| HUMATROPE | ELI LILLY CANADA INC | To be discontinued | 1MG | Updated Report | 2020-05-11 | 106800 |
